We measured m6A sites in the AML cell lines MONOMAC-6 and MOLM-13, as well as in HEK293T cells, under conditions of FTO knockdown, FTO knockout, and pharmacologic FTO inhibition. This evidence concerns the gene FTO and acute myeloid leukemia.